Could Viking Therapeutics Become the Next Novo Nordisk?

Given this biotech's ascent, its odds of becoming a giant are better than most. The much-feted biotech Viking Therapeutics (VKTX -0.51%) is aiming for Novo Nordisk's (NVO -1.58%) cash cow, the market for weight loss drugs. If its ambitions are fulfilled, it has a shot at becoming as large as its big pharma rival. To see why this possibility is more than a pipe dream, let's start by making some quick calculations. That will help us to understand Viking's chances of becoming the next Novo Nordisk, based on ho ...